Abstract:BackgroundAlzheimer’s disease (AD) neuropathology reveals progressive microstructural alterations of cortical architecture. Recent studies reported intriguing biphasic trajectories of cortical structural changes in the early stages of Alzheimer’s disease (AD), comprising decreased mean diffusivity (MD) and increased cortical thickness in cognitively normal amyloid-positive individuals, ahead of increases and decreases, respectively, in subsequent disease stages.ObjectiveTo better understand the cytoarchitectural correlates of these observations, we assessed novel cortical diffusion tensor imaging (DTI) metrics that are correlated with disruption of cortical minicolumns and protein deposition.DesignCross-sectional and longitudinal analysis of whole brain and temporal lobe cortical diffusivity measures. Investigation of associations between baseline cortical diffusivity values and 24-month longitudinal structural-MRI changes. Investigations of the relationships between cortical diffusivity measures and biomarkers of neuroinflammation.SettingAlzheimer’s Disease Neuroimaging Initiative (ADNI).ParticipantsTwenty-four amyloid-negative controls (CN-), 28 amyloid-positive controls (CN+), 46 amyloid-positive subjects with mild cognitive impairment (MCI+) and 22 amyloid-positive subjects with AD were included.Measurements3DT1 and DTI scans at baseline and approximately 24-month follow-up were used to calculate cortical MD and three novel cortical diffusivity measures: the angle between the radial minicolumnar axis and the principal diffusion direction (AngleR); the diffusion components perpendicular to the minicolumns (PerpPD+), and the principal diffusion component parallel with the minicolumns (ParlPD). Cortical macrostructural measurements (cortical volume fraction and cortical thickness), were used to test the hypothesis that baseline cortical diffusivity values can predict change in structural MRI outcomes over approximately 24 months. CSF soluble TREM2 and progranulin (PGRN) concentrations were used to investigate associations with microglial activity and potentially other aspects of neuroinflammation.ResultsCortical diffusivity metrics revealed a dependence on disease stage, with AngleR and PerpPD+ displaying biphasic relationships and ParlPD a monotonic relationship with clinical severity. The novel metrics were able to differentiate between Amyloid+ and Amyloid- controls (AngleR) and to differentiate among disease stages along the AD continuum (PerpPD+). Linear regression revealed significant associations between baseline cortical diffusivity values and subsequent 24-month longitudinal structural-MRI changes. AngleR values were significantly associated with CSF sTREM2 and PGRN concentrations.ConclusionsCortical diffusivity parameters reflecting minicolumnar organization and neuroinflammation may provide a sensitive and biologically interpretable measurement of cortex quality and microstructure across the AD continuum.

Cortical thickness modeling and variability in Alzheimer's disease and frontotemporal dementia

Cortical folding correlates to aging and Alzheimer's Disease's cognitive and CSF biomarkers

Cortical Thickness Across the Lifespan in a Colombian Cohort with Autosomal-Dominant Alzheimer's Disease: A Cross-Sectional Study.

Early Cortical Microstructural Changes in Aging Are Linked to Vulnerability to Alzheimer's Disease Pathology

Frontoparietal atrophy trajectories in cognitively unimpaired elderly individuals using longitudinal Bayesian clustering

Factors influencing accuracy of cortical thickness in the diagnosis of Alzheimer's disease

Distinct spatiotemporal patterns of cortical thinning in Alzheimer's disease-type cognitive impairment and subcortical vascular cognitive impairment

Joint signatures of morphological and microstructural inter-individual variation in the Alzheimer’s spectrum

Longitudinal Changes in Surface Based Brain Morphometry Measures in Amnestic Mild Cognitive Impairment and Alzheimer's Disease

Increased Cortical Thickness in Alzheimer's Disease

Cortical Gyrification and Sulcal Spans in Early Stage Alzheimer's Disease

Synthesizing longitudinal cortical thickness estimates with a flexible and hierarchical multivariate measurement-error model

In Vivo Detection of Changes Related to Cortical Columnar Organization and Neuroinflammation Across the AD Continuum

Novel Cortical Thickness Pattern for Accurate Detection of Alzheimer's Disease.

Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative

The Cortical Neuroanatomy Related to Specific Neuropsychological Deficits in Alzheimer's Continuum

Select Atrophied Regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia

Dissociable Cellular and Genetic Mechanisms of Cortical Thinning at Different Life Stages

Correlations between Cerebrospinal Fluid Biomarkers and Gray Matter Atrophy in Alzheimer's and Behavioural Variant Frontotemporal Dementia

Discriminant Analysis of Longitudinal Cortical Thickness Changes in Alzheimer's Disease Using Dynamic and Network Features

Graded Multidimensional Clinical and Radiologic Variation in Patients With Alzheimer Disease and Posterior Cortical Atrophy